Cytocom
Cozette McAvoy, Esq., has been serving as Chief Legal Officer for Cytocom Inc. since May 2020.
Prior to holding this position, Ms. McAvoy served as Senior Vice President, Transactions and Head of Intellectual Property at Amyris, Inc. (Nasdaq: AMRS), a synthetic biotechnology company from February 2017 to April 2020. Ms. McAvoy served as Vice President, Deputy General Counsel at G&W Pharmaceuticals, Inc., responsible for leading the company’s contracting and intellectual property functions and the integration and support of products and manufacturing facilities from Nov. 2015 to Oct. 2016.
This person is not in any offices
Cytocom
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.